These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Successful treatment of posttraumatic hemiballismus with intrathecal baclofen therapy. Francisco GE Am J Phys Med Rehabil; 2006 Sep; 85(9):779-82. PubMed ID: 16924190 [TBL] [Abstract][Full Text] [Related]
28. Focal dystonia, with special reference to writer's cramp. Gordon NS Int J Clin Pract; 2005 Sep; 59(9):1088-90. PubMed ID: 16115186 [TBL] [Abstract][Full Text] [Related]
29. Cerebrospinal fluid baclofen concentrations in patients undergoing continuous intrathecal baclofen therapy. Albright AL; Thompson K; Carlos S; Minnigh MB Dev Med Child Neurol; 2007 Jun; 49(6):423-5. PubMed ID: 17518926 [TBL] [Abstract][Full Text] [Related]
30. [Intrathecal perfusion pump with baclofen in generalized dystonia]. Grande MA; Chacón J; Trujillo A; García-Moreno JM; Bravo M Rev Neurol; 2000 Jan 16-31; 30(2):138-40. PubMed ID: 10730320 [TBL] [Abstract][Full Text] [Related]
31. Anticholinergics in adult-onset focal dystonia. Lang AE; Sheehy MP; Marsden CD Can J Neurol Sci; 1982 Aug; 9(3):313-9. PubMed ID: 7116238 [TBL] [Abstract][Full Text] [Related]
32. Effect of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. Motta F; Stignani C; Antonello CE J Pediatr Orthop; 2008 Mar; 28(2):213-7. PubMed ID: 18388717 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study. Lim EC; Quek AM; Seet RC Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081 [TBL] [Abstract][Full Text] [Related]
34. kinesiotaping reduces pain and modulates sensory function in patients with focal dystonia: a randomized crossover pilot study. Pelosin E; Avanzino L; Marchese R; Stramesi P; Bilanci M; Trompetto C; Abbruzzese G Neurorehabil Neural Repair; 2013 Oct; 27(8):722-31. PubMed ID: 23764884 [TBL] [Abstract][Full Text] [Related]
35. The dystonia discomfort scale (DDS): a novel instrument to monitor the temporal profile of botulinum toxin therapy in cervical dystonia. Dressler D; Kupsch A; Seitzinger A; Paus S Eur J Neurol; 2014 Mar; 21(3):459-62. PubMed ID: 24433495 [TBL] [Abstract][Full Text] [Related]
36. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study). Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065 [TBL] [Abstract][Full Text] [Related]
37. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]